Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
5.13
-0.05 (-0.97%)
At close: Dec 5, 2025, 4:00 PM EST
5.15
+0.02 (0.39%)
After-hours: Dec 5, 2025, 7:57 PM EST
Sana Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -234.41 | -266.76 | -283.26 | -269.48 | -355.93 | -285.31 | |
| Depreciation & Amortization | 13.5 | 15.5 | 17.54 | 15.63 | 11.07 | 5.92 | |
| Asset Writedown & Restructuring Costs | 46.5 | 1.89 | 7.01 | - | - | - | |
| Stock-Based Compensation | 25.56 | 37.68 | 35.53 | 38.34 | 22.36 | 5.83 | |
| Other Operating Activities | -0.25 | -10.28 | -49.03 | -82.08 | 61.64 | 129.42 | |
| Change in Accounts Payable | -1.08 | 1.38 | 1.03 | 1.06 | -0.27 | 1.98 | |
| Change in Other Net Operating Assets | -8.18 | -2.56 | 17.58 | 6.48 | 10.07 | 4.17 | |
| Operating Cash Flow | -158.35 | -223.15 | -253.58 | -290.05 | -251.05 | -137.98 | |
| Capital Expenditures | -0.5 | -33.43 | -20.03 | -20.88 | -29.86 | -23.87 | |
| Investment in Securities | 23.08 | 50.88 | 192.04 | 231.44 | -211.36 | -228.69 | |
| Other Investing Activities | - | - | - | - | -4.57 | - | |
| Investing Cash Flow | 23.35 | 17.45 | 172.01 | 210.56 | -245.8 | -252.56 | |
| Long-Term Debt Issued | - | 7.74 | - | - | - | - | |
| Net Debt Issued (Repaid) | -0.31 | 7.74 | - | - | - | - | |
| Issuance of Common Stock | 112.04 | 192.01 | 31.65 | 4.91 | 631.75 | 0.15 | |
| Financing Cash Flow | 111.73 | 199.75 | 31.65 | 4.91 | 631.75 | 435.69 | |
| Net Cash Flow | -23.28 | -5.95 | -49.92 | -74.58 | 134.9 | 45.14 | |
| Free Cash Flow | -158.85 | -256.58 | -273.61 | -310.93 | -280.92 | -161.85 | |
| Free Cash Flow Per Share | -0.65 | -1.11 | -1.41 | -1.65 | -1.69 | -12.44 | |
| Levered Free Cash Flow | -93.53 | -168.6 | -206.93 | -140.89 | -138.16 | -166.01 | |
| Unlevered Free Cash Flow | -93.53 | -168.6 | -206.93 | -140.89 | -138.16 | -166.01 | |
| Change in Working Capital | -9.26 | -1.19 | 18.61 | 7.54 | 9.8 | 6.16 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.